Find verified Upadacitinib API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Upadacitinib for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Upadacitinib API.
Alternate Names: Upadacitinib anhydrous
CAS No: 1310726-60-3
PubChem CID: 58557659
Mol Formula: C17H19F3N6O
Mol Weight: 380.4 g/mol
IUPAC Name: (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxam -Show More
API Description: Upadacitinib is an oral selective inhibitor of Janus associated kinase 1 (JAK-1) that is used in the therapy of moderate-to-severe rheumatoid arthritis. Upadacitinib has been associated with a low rate of serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent acute liver injury although it may pose a risk for reactivation of hepatitis B in susceptible patients.
